期刊文献+

Synthesis of Novel Flavanone Derivatives and Their Anti Staphylococcus aureus Evaluation 被引量:1

Synthesis of Novel Flavanone Derivatives and Their Anti Staphylococcus aureus Evaluation
原文传递
导出
摘要 The authors synthesized two novel flavanones bearing iso-pentenyl side chain and evaluated their anti Staphylococcus aureus(S.aureus) activity.The target compounds 7a[2-5'-(l",2"-dimethylallyl)-2'-methoxy-4',5,7-tetrahydroxyflavanone] and 7b[2-5'-(l",2"-dimethylallyl)-3'-methoxy-4',5,7-tetrahydroxyflavanone] were synthesized respectively through total four steps starting from 2,4,6-trihydroxy acetophenone(3) and the corresponding iso-pentenyl substituted benzaldehyde(1),in which the 1,2-dimethyl-2-propenyl group had been introduced previously via abnormal Claisen rearrangement.The bioactivities of the two flavanones against S.aureus strains ATCC 25923,29213,and MRSA 252 were evaluated,showing the same minimum inhibitory concentration(MIC) value of 16 μg/mL. The authors synthesized two novel flavanones bearing iso-pentenyl side chain and evaluated their anti Staphylococcus aureus(S.aureus) activity.The target compounds 7a[2-5'-(l",2"-dimethylallyl)-2'-methoxy-4',5,7-tetrahydroxyflavanone] and 7b[2-5'-(l",2"-dimethylallyl)-3'-methoxy-4',5,7-tetrahydroxyflavanone] were synthesized respectively through total four steps starting from 2,4,6-trihydroxy acetophenone(3) and the corresponding iso-pentenyl substituted benzaldehyde(1),in which the 1,2-dimethyl-2-propenyl group had been introduced previously via abnormal Claisen rearrangement.The bioactivities of the two flavanones against S.aureus strains ATCC 25923,29213,and MRSA 252 were evaluated,showing the same minimum inhibitory concentration(MIC) value of 16 μg/mL.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2013年第4期695-698,共4页 高等学校化学研究(英文版)
关键词 FLAVANONE Abnormal Claisen rearrangement ANTIMICROBIAL iso-Pentenyl side chain Flavanone Abnormal Claisen rearrangement Antimicrobial iso-Pentenyl side chain
  • 相关文献

参考文献26

  • 1Levy S. B., Marshall B., Nat. Med., 2004, 10, 122.
  • 2Barrett J. E, Expert Opin. Ther. Targets, 2005, 9, 253.
  • 3Bryskier A., Expert Rev Anti. Infect Ther., 2005, 3, 505.
  • 4Walsh C. T., Nat. Rev. Microbiol., 2003, 1, 65.
  • 5Ding Y. J., Nie Y., Yu Y., Chem. Res. Chinese Universities, 2011, 27(4), 651.
  • 6Mitchell M. O., Anti. Infect. Agents Med. Chem., 2007, 6, 243.
  • 7Arias C. A., Murray B. E. N., Eng. J Med., 2009, 360, 439.
  • 8Liu X. L., Eur. J Med. Chem., 2008, 43, 1681.
  • 9Straus S. K.,. Hancock. R. E. W., Biochim. Biophys. Acta, 2006, 1758, 1215.
  • 10Tanaka H., Sato M., Fujiwara S., Hiram M., Lett. AppL Microbiol., 2002, 35, 494.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部